CUSIP: 26886A101
Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM CL A
-
Total 13F shares
-
19,605,957
-
Share change
-
+845,543
-
Total reported value
-
$193,612,000
-
Price per share
-
$9.88
-
Number of holders
-
74
-
Value change
-
+$8,415,865
-
Number of buys
-
29
-
Number of sells
-
17
Quarterly Holders Quick Answers
What is CUSIP 26886A101?
CUSIP 26886A101 identifies EQHA - EQ HEALTH ACQUISITION CORP - COM CL A in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q4 2022
-
Previous quarter:
Q2 2022
Recent filing periods for CUSIP 26886A101:
Institutional Holders of EQ HEALTH ACQUISITION CORP - COM CL A (EQHA) as of Q3 2022
As of 30 Sep 2022,
EQ HEALTH ACQUISITION CORP - COM CL A (EQHA) was held by
74 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
19,605,957 shares.
The largest 10 holders included
Saba Capital Management, L.P., GLAZER CAPITAL, LLC, MILLENNIUM MANAGEMENT LLC, MARSHALL WACE, LLP, Hudson Bay Capital Management LP, Periscope Capital Inc., GOLDMAN SACHS GROUP INC, Magnetar Financial LLC, Castle Creek Arbitrage, LLC, and ARISTEIA CAPITAL LLC.
This page lists
74
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.